This cannabinoids mental health meta-analysis reviews 54 randomized trials across psychiatric and substance use conditions. It identifies modest benefits in insomnia, Tourette syndrome, ASD traits, and cannabis withdrawal, but with low certainty. For most mental health conditions, the evidence does not support routine prescribing.